Roger Schibli
23Patents
6h-index
31Co-inventors
69Inventor score
Filing activity: Oct 22, 1999 → Dec 18, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9764038B2 | Enzymatic conjugation of antibodies | Chemistry; Metallurgy | 23 | Active |
| US6344178B1 | Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates | Chemistry; Metallurgy | 19 | Expired |
| US9427478B2 | Enzymatic conjugation of polypeptides | Chemistry; Metallurgy | 17 | Active |
| US9717803B2 | Enzymatic conjugation of polypeptides | Chemistry; Metallurgy | 12 | Active |
| US7053242B1 | Carbon monoxide source for preparation of transition-metal-carbonyl-complexes | Chemistry; Metallurgy | 9 | Expired |
| US10434180B2 | Enzymatic conjugation of polypeptides | Chemistry; Metallurgy | 7 | Active |
| US9295739B2 | Folate conjugates of albumin-binding entities | Chemistry; Metallurgy | 4 | Active |
| US7188725B2 | Kits for preparing transition metal carbonyl complexes | Chemistry; Metallurgy | 3 | Expired |
| US10675359B2 | Enzymatic conjugation of antibodies | Chemistry; Metallurgy | 3 | Active |
| US10132799B2 | Screening of conjugated antibodies | Chemistry; Metallurgy | 2 | Active |
| US10130724B2 | Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment | Physics | 2 | Active |
| US11396649B2 | Site-specific conjugation to antibody lysine residues with solid-phase immobilized microbial transglutaminase MTG and MTG in solution | Chemistry; Metallurgy | 2 | Active |
| US11629201B2 | PSMA-binding agents and uses thereof | Human Necessities | 1 | Active |
| US10973936B2 | 18F-saccharide-folates | Emerging Cross-Sectional Technologies | 0 | Active |
| US11649268B2 | Fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy | Human Necessities | 0 | Active |
| US10961246B2 | 18F-labelled folates as PET radiotracers | Human Necessities | 0 | Active |
| US11623014B2 | Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment | Physics | 0 | Active |
| US10357576B2 | 18F-labelled folate/antifolate analogues | Physics | 0 | Active |
| US9265746B2 | Method for cell-specific targeting | Human Necessities | 0 | Active |
| US10322195B2 | 18F-saccharide-folates | Emerging Cross-Sectional Technologies | 0 | Active |
| US12128110B2 | Transglutaminase conjugation method and linker | Chemistry; Metallurgy | 0 | Active |
| US12023390B2 | Isomerically pure 18F-labelled tetrahydrofolates | Human Necessities | 0 | Active |
| US10953114B2 | Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.